Barrett's esophagus represents a premalignant condition, which is strongly associated with
the incidence of esophageal adenocarcinoma. Currently, there are no validated markers to …

The clinical value of endoscopic ablation of nondysplastic Barrett's epithelium is
controversial. It has been stated that ablation, combined with acid suppression or antireflux …

Barrett's oesophagus (BO) is thought to progress through the development of dysplasia (low
grade and high grade) to oesophageal adenocarcinoma, a lethal cancer with poor survival …

Background and study aim: Endoscopic resection with radiofrequency ablation (RFA) 6
weeks later safely and effectively eradicates Barrett's esophagus with high grade dysplasia …

The absolute incidence of esophageal adenocarcinoma has increased 7-fold over the past 5
decades, and esophageal adenocarcinoma is the most rapidly increasing epithelial …

BACKGROUND & AIMS: Radiofrequency ablation (RFA) is safe and effective for eradicating
intestinal metaplasia and neoplasia in patients with Barrett's esophagus. We sought to …

Because of the morbidity and mortality that may be associated with esophagectomy, less
invasive endoscopic treatment modalities have emerged to treat high− grade dysplasia …

Endotherapy is now the mainstay of therapy for Barrett's associated neoplasia. The
approach should begin with confirmation of neoplasia by a gastrointestinal pathologist …

Barrett's esophagus (BE) is a premalignant condition in which the normal squamous cell
lining of the esophagus is replaced by columnar epithelium containing specialized intestinal …

This review provides a summary of our current understanding of, and the controversies
surrounding, the diagnosis, pathogenesis, histopathology, and molecular biology of Barrett's …